158022-12-9

Basic information

• Product Name: FTASE INHIBITOR III
• Synonyms: CYS-VAL-2-NAPTHYL-3-ALANYL-MET;CV-2-Nal-M;FTASE INHIBITOR III;H-CYS-VAL-2-NAL-MET-OH;H-CYS-VAL-ALA(2-NAPHTHYL)-MET-OH;CYS-VAL-2-NAL-MET
• CAS NO: 158022-12-9
• Molecular Formula: C26H36N4O5S2
• Molecular Weight: 548.72
• Product Categories: Farnesyl transferase, p21rasPeptides for Cell Biology;Farnesyltransferase, p21rasG Proteins and Cyclic Nucleotides;D to;Enzyme Inhibitors;Enzyme Inhibitors by Enzyme;G Protein Function;Post-translational Modification
• Mol File: 158022-12-9.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: −20°C
• CAS DataBase Reference: FTASE INHIBITOR III(CAS DataBase Reference)
• NIST Chemistry Reference: FTASE INHIBITOR III(158022-12-9)
• EPA Substance Registry System: FTASE INHIBITOR III(158022-12-9)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 158022-12-9(Hazardous Substances Data)

Usage

General Description

FTASE INHIBITOR III is a small molecule inhibitor that targets the farnesyltransferase enzyme, which is involved in the post-translational farnesylation of proteins. Farnesylation is a process that adds a lipid group to the C-terminal of proteins, allowing them to be anchored to cell membranes. By inhibiting this process, FTASE INHIBITOR III has the potential to disrupt the function of certain proteins that are implicated in cancer and other diseases. Research has shown that FTASE INHIBITOR III can effectively block the farnesylation of specific proteins, making it a promising candidate for the development of targeted therapies for various diseases.